The Marketstrat Pulse — ROI Telemetry Becomes the Moat: Imaging AI Shifts From ‘Accuracy’ to Measurable Capacity + Revenue (Feb 6, 2026)
ONE BIG THING Imaging AI crossed a commercial Rubicon this week: reimbursement tightened (NGS draft noncoverage for brain MRI AI quantification) while “ROI telemetry” emerged as the winning sales language—AI is increasingly bought as measurable capacity-and-revenue infrastructure, not a standalone accuracy feature. KEY TAKEAWAYS MARKETSTRAT POV (ACTIONABLE STRATEGY) INNOVATION HOOK ROI telemetry becomes the moat”: […]
Markintel Pulse Insights — Imaging AI Becomes Infrastructure: Foundation Models + Outcome-Grade Evidence (Jan 30, 2026)
ONE BIG THING Randomized, population-scale evidence now shows AI-supported mammography can reduce interval cancers while materially lowering radiologist reading workload, pushing imaging AI from “pilot productivity tool” to quality-and-capacity infrastructure for national screening programs. KEY TAKEAWAYS MARKETSTRAT POV (ACTIONABLE STRATEGY) INNOVATION HOOK Outcomes-grade screening AI becomes a capacity lever, not just a detection tool This […]
Markintel Pulse Insights — Radiology AI Shifts from Apps to Platforms (Jan 23, 2026)
ONE BIG THING Imaging AI is splitting into two winning lanes—multi‑indication “operational triage” that earns enterprise budgets and clearances, and a GenAI “explainability layer” forced by transparency rules—while payer scrutiny tightens the bar for anything that can’t prove measurable outcomes. KEY TAKEAWAYS MARKETSTRAT POV (ACTIONABLE STRATEGY) INNOVATION HOOK The “Explainability Layer” Becomes the New ROI […]
Markintel Pulse Insights — MRI Automation Becomes the Capacity Lever – JAN 16, 2026
ONE BIG THING Imaging AI’s “center of value” moved upstream this week—away from interpretation-only tools and toward acquisition automation + open foundation models that directly translate into throughput, staffing leverage, and faster access. KEY TAKEAWAYS MARKETSTRAT POV (ACTIONABLE STRATEGY) INNOVATION HOOK MRI demand continues rising while technologist scarcity and protocol complexity cap throughput. This week’s […]
MARKINTEL PULSE – WEEKLY MEDTECH, IMAGING & DIGITAL HEALTH INSIGHTS – JAN 9, 2026
ONE BIG THING FDA’s Jan‑6 guidance pair (CDS + General Wellness) materially widens the “non‑device” lane for AI in care delivery—shifting near‑term advantage from model performance to defensible deployment economics (workflow fit, evidence, liability controls, and integration). KEY TAKEAWAYS MARKETSTRAT POV (ACTIONABLE STRATEGY) INNOVATION HOOK Bedside imaging is becoming an economic weapon For imaging providers, […]
MARKINTEL PULSE – WEEKLY MEDTECH, IMAGING & DIGITAL HEALTH INSIGHTS – DEC 19, 2025
ONE BIG THING Imaging AI is shifting from “algorithm shelfware” to system-level workflow infrastructure — and this week’s mix of foundation-model progress, enterprise neuro workflow partnerships, and cath-lab AI M&A signals a platform land-grab that will redefine how imaging revenue is captured (through throughput, pathways, and coordination), not just per-study detection accuracy. KEY TAKEAWAYS MARKETSTRAT […]
MARKINTEL PULSE – WEEKLY MEDTECH, IMAGING & DIGITAL HEALTH INSIGHTS – DEC 12, 2025
ONE BIG THING One Big Thing: RSNA 2025 confirmed that “AI in imaging” is no longer a feature race—it’s an operating-layer land grab where cloud enterprise imaging, workflow copilots, and hardware-native AI converge into platform economics (recurring revenue, attach, and lock-in) with early, measurable productivity proof-points. Market Lens baseline (house view): AI-in-Imaging TAM = $28.4B […]
RSNA 2025 Day 3 Signals – Risk Biomarkers, AI Governance and AI‑native Imaging Workflows
Key Takeaways – RSNA 2025 Day 3 Major Vendor Bets Innovation Hook – From Pixels to Prevention Programs RSNA 2025’s Day 3 signal is not another gadget or one more AI algorithm. It’s the convergence of: For Marketstrat’s clients, the strategic question coming out of Day 3 is: How quickly can you move from “demo‑ready […]
RSNA 2025 Day 2 Signals – AI factories, screening evidence and digital twin diagnostics
Key Takeaways Major Vendor Bets RSNA25 – Day 2 Signals Selected Day 2 Vendor Initiatives Selected RSNA 2025 Day 2 initiatives mapped to Marketstrat’s core signals and strategic implications Vendor / initiative RSNA 2025 highlight (Day 2 cluster) Signal(s) touched Marketstrat read‑out Aidoc Partners with NVIDIA MONAI & Quibim to let health systems deploy in‑house […]
RSNA 2025 – Day 1 Signals: Hardware, Native AI and the Battle for Radiology’s Operating Layer
From AI‑native MRI and CT to clinical AI foundation models and enterprise operations platforms, Day 1 at RSNA 2025 showed how fast imaging hardware, software and workflows are converging. What Stood Out Across Philips, GE HealthCare, Siemens Healthineers, United Imaging, Aidoc, Coreline Soft and Rad AI, four cross‑cutting signals defined Day 1: From Marketstrat’s perspective, […]
